Speakers 2022

Speakers 2022

Pascale BOUILLÉ

Flash Therapeutics

CEO


A LENTIVIRAL PLATFORM FOR EFFICIENT AND SAFE RNA DELIVERY

September 21th

Pascale founded the company, Flash Therapeutics (FTX), in 2005. She provides her deep scientific expertise in the field of gene delivery and her breakthrough vision of gene therapies based on RNA. Pascale has led the successful transition of FTX from a research based start-up to a GMP bio-production biotech and a commercially-oriented product company.   Pascale has over 25 years of experience in genetic delivery, and has been involved in multiple gene therapy programs in different therapeutic areas including genetic diseases, cancer and degenerative disorders.   Pascale Bouillé served as project leader in a number of government and biotechnology research laboratories. She conducted gene therapy programs from discovery to clinical at Genethon laboratories in collaboration with Harvard Medical School. Previously, Pascale served as a virologist at Pasteur and Gustave Roussy Institutes. Pascale Bouillé holds a PhD in Molecular Virology from Université Pierre et Marie Curie, Paris. She completed her scientific skills by management, finance, strategy and commercial training at Institut Français de Gestion (IFG), HEC executive and a dedicated management program at Stanford Graduate School of Business (Women Entrepreneur Program).

Find also